Joined May 2023 (3 years on Bluesky)
Followers
4.1K
Growth (7d)
+3
Following
1.4K
Posts
2.5K~2.2/day
Influence
13
Follower growth
2026-06-14+2 over 2 days2026-06-22
Bio
Thoracic Medical Oncologist at the Ohio State University s/p University of Texas, Rutgers, NCI, UC Davis | Aspiring clinical trialist | Interested in developing novel immunotherapy and cell therapy in lung cancer #MedSky #OncSky #lcsm
Notable followers
The biggest accounts in our directory following @jinesh.bsky.social.
More Education accounts
Senator Bernie Sanders
@sanders.senate.gov
572K
followers
Timothy Snyder
@timothysnyder.bsky.social
484K
followers
Paul Krugman
@pkrugman.bsky.social
316K
followers
Science Friday
@scifri.bsky.social
233K
followers
Asawin Suebsaeng
@swin24.bsky.social
198K
followers
Shannon Watts
@shannonrwatts.bsky.social
193K
followers
Stephanie Kennedy
@wordswithsteph.bsky.social
185K
followers
David Shiffman, Ph.D. 🦈
@whysharksmatter.bsky.social
164K
followers
Jinesh Gheeya, MD, PhD on Bluesky - frequently asked questions
- How many followers does Jinesh Gheeya, MD, PhD have on Bluesky?
- Jinesh Gheeya, MD, PhD (@jinesh.bsky.social) currently has 4,080 followers on Bluesky, gaining 3 new followers in the last 7 days. The count is refreshed continuously from the public AT Protocol.
- When did Jinesh Gheeya, MD, PhD join Bluesky?
- Jinesh Gheeya, MD, PhD joined Bluesky in May 2023, making the account about 3 years old.
- How many posts has Jinesh Gheeya, MD, PhD published?
- Jinesh Gheeya, MD, PhD has published 2,513 posts on Bluesky, averaging about 2.2 posts per day over the account's lifetime.
- Is Jinesh Gheeya, MD, PhD verified on Bluesky?
- @jinesh.bsky.social does not currently show a Bluesky verification. Many real accounts on Bluesky are unverified, since verification is still rolling out.
- What does Jinesh Gheeya, MD, PhD post about?
- Jinesh Gheeya, MD, PhD is classified under Education in our directory. Bio: "Thoracic Medical Oncologist at the Ohio State University s/p University of Texas, Rutgers, NCI, UC Davis | Aspiring clinical trialist | Interested in developing novel immunotherapy and cell therapy in".